1. Lloyd RV, Osamura RY, Kloppel G, Rosai J. WHO classification of tumors of endocrine organs; 4th ed. Lyon: International Agency for Research on Cancer (IARC); 2017. p. 65-91.
2. Zhu Y, Li Y, Jung CK, Song DE, Hang JF, Liu Z, et al. Histopathologic assessment of capsular invasion in follicular thyroid neoplasms-an observer variation study. Endocr Pathol 2020;31:132-40.
[CROSSREF] [PUBMED]
3. Liu Z, Bychkov A, Jung CK, Hirokawa M, Sui S, Hong S, et al. Interobserver and intraobserver variation in the morphological evaluation of noninvasive follicular thyroid neoplasm with papillary-like nuclear features in Asian practice. Pathol Int 2019;69:202-10.
[CROSSREF] [PUBMED]
4. Nikiforov YE, Seethala RR, Tallini G, Baloch ZW, Basolo F, Thompson LD, et al. Nomenclature revision for encapsulated follicular variant of papillary thyroid carcinoma: a paradigm shift to reduce overtreatment of indolent tumors. JAMA Oncol 2016;2:1023-9.
[CROSSREF] [PUBMED] [PMC]
5. Nikiforov YE, Baloch ZW, Hodak SP, Giordano TJ, Lloyd RV, Seethala RR, et al. Change in diagnostic criteria for noninvasive follicular thyroid neoplasm with papillarylike nuclear features. JAMA Oncol 2018;4:1125-6.
[CROSSREF] [PUBMED] [PMC]
6. Cancer Genome Atlas Research Network. Integrated genomic characterization of papillary thyroid carcinoma. Cell 2014;159:676-90.
[PUBMED] [PMC]
7. Fagin JA, Wells SA Jr. Biologic and clinical perspectives on thyroid cancer. N Engl J Med 2016;375:1054-67.
[CROSSREF] [PUBMED] [PMC]
8. Tirro E, Martorana F, Romano C, Vitale SR, Motta G, Di Gregorio S, et al. Molecular alterations in thyroid cancer: from bench to clinical practice. Genes (Basel) 2019;10:709.
[CROSSREF] [PUBMED] [PMC]
9. Paulson VA, Shivdasani P, Angell TE, Cibas ES, Krane JF, Lindeman NI, et al. Noninvasive follicular thyroid neoplasm with papillary-like nuclear features accounts for more than half of “carcinomas” harboring RAS mutations. Thyroid 2017;27:506-11.
[CROSSREF] [PUBMED]
10. Kakudo K. Thyroid FNA cytology; 2nd ed. Singapore: Springer Nature Singapore Pte Ltd; 2019. Chapter 21, Nuclear features of papillary thyroid carcinoma (BRAF-like tumors), noninvasive follicular thyroid neoplasm with papillary-like nuclear features (RAS-like tumors), and follicular adenoma/follicular thyroid carcinoma (RAS-like tumors). p. 173-9.
11. Hirokawa M, Carney JA, Goellner JR, DeLellis RA, Heffess CS, Katoh R, et al. Observer variation of encapsulated follicular lesions of the thyroid gland. Am J Surg Pathol 2002;26:1508-14.
[CROSSREF] [PUBMED]
12. Rosai J. The encapsulated follicular variant of papillary thyroid carcinoma: back to the drawing board. Endocr Pathol 2010;21:7-11.
[CROSSREF] [PUBMED]
13. Bychkov A, Jung CK, Liu Z, Kakudo K. Noninvasive follicular thyroid neoplasm with papillary-like nuclear features in Asian practice: perspectives for surgical pathology and cytopathology. Endocr Pathol 2018;29:276-88.
[CROSSREF] [PUBMED] [PMC]
14. Bychkov A, Keelawat S, Agarwal S, Jain D, Jung CK, Hong S, et al. Impact of non-invasive follicular thyroid neoplasm with papillary-like nuclear features on the Bethesda system for reporting thyroid cytopathology: a multi-institutional study in five Asian countries. Pathology 2018;50:411-7.
[CROSSREF] [PUBMED]
15. Hirokawa M, Higuchi M, Suzuki A, Hayashi T, Kuma S, Miyauchi A. Prevalence and diagnostic significance of noninvasive follicular thyroid neoplasm with papillary-like nuclear features among tumors previously diagnosed as follicular adenoma: a single-institutional study in Japan. Endocr J 2020;67:1071-5.
[CROSSREF] [PUBMED]
16. Zajkowska K, Kopczynski J, Gozdz S, Kowalska A. Noninvasive follicular thyroid neoplasm with papillary-like nuclear features: a problematic entity. Endocr Connect 2020;9:R47-58.
[CROSSREF] [PUBMED] [PMC]
17. Cho U, Mete O, Kim MH, Bae JS, Jung CK. Molecular correlates and rate of lymph node metastasis of non-invasive follicular thyroid neoplasm with papillary-like nuclear features and invasive follicular variant papillary thyroid carcinoma: the impact of rigid criteria to distinguish non-invasive follicular thyroid neoplasm with papillary-like nuclear features. Mod Pathol 2017;30:810-25.
[CROSSREF] [PUBMED]
18. Jung CK, Kim Y, Jeon S, Jo K, Lee S, Bae JS. Clinical utility of EZH1 mutations in the diagnosis of follicular-patterned thyroid tumors. Hum Pathol 2018;81:9-17.
[CROSSREF] [PUBMED]
19. Bychkov A, Kakudo K, Hong S. Current practices of thyroid fine-needle aspiration in Asia: a missing voice. J Pathol Transl Med 2017;51:517-20.
[CROSSREF] [PUBMED] [PMC]
20. Jung CK, Hong S, Bychkov A, Kakudo K. The use of fine-needle aspiration (FNA) cytology in patients with thyroid nodules in Asia: a brief overview of studies from the Working Group of Asian Thyroid FNA Cytology. J Pathol Transl Med 2017;51:571-8.
[CROSSREF] [PUBMED] [PMC]
21. Rossi ED, Bizzarro T, Martini M, Capodimonti S, Fadda G, Larocca LM, et al. Morphological parameters able to predict BRAF(V600E) mutated malignancies on thyroid fine-needle aspiration cytology: our institutional experience. Cancer Cytopathol 2014;122:883-91.
[CROSSREF] [PUBMED]
22. Legesse T, Parker L, Heath J, Staats PN. Distinguishing non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) from classic and invasive follicular-variant papillary thyroid carcinomas based on cytologic features. J Am Soc Cytopathol 2019;8:11-7.
[CROSSREF] [PUBMED]
23. Mahajan S, Agarwal S, Kocheri N, Jain D, Mathur SR, Iyer VK. Cytopathology of non-invasive follicular thyroid neoplasm with papillary-like nuclear features: a comparative study with similar patterned papillary thyroid carcinoma variants. Cytopathology 2018;29:233-40.
[CROSSREF] [PUBMED]
24. Arora SK, Dey P. Intranuclear peudoinclusions: morphology, pathogenesis, and significance. Diagn Cytopathol 2012;40:741-4.
[CROSSREF] [PUBMED]
25. Ip YT, Dias Filho MA, Chan JK. Nuclear inclusions and pseudoinclusions: friends or foes of the surgical pathologist? Int J Surg Pathol 2010;18:465-81.
[CROSSREF] [PUBMED]
26. Das DK. Intranuclear cytoplasmic inclusions in fine-needle aspiration smears of papillary thyroid carcinoma: a study of its morphological forms, association with nuclear grooves, and mode of formation. Diagn Cytopathol 2005;32:264-8.
[CROSSREF] [PUBMED]
27. Alves VA, Kakudo K, LiVolsi V, Lloyd RV, Nikiforov YE, Nose V, et al. Noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): achieving better agreement by refining diagnostic criteria. Clinics (Sao Paulo) 2018;73:e576.
[CROSSREF] [PUBMED] [PMC]
28. Thompson LD, Poller DN, Kakudo K, Burchette R, Nikiforov YE, Seethala RR. An international interobserver variability reporting of the nuclear scoring criteria to diagnose noninvasive follicular thyroid neoplasm with papillary-like nuclear features: a validation study. Endocr Pathol 2018;29:242-9.
[CROSSREF] [PUBMED]
29. Choi JE, Bae JS, Lim DJ, Jung SL, Jung CK. Atypical histiocytoid cells and multinucleated giant cells in fine-needle aspiration cytology of the thyroid predict lymph node metastasis of papillary thyroid carcinoma. Cancers (Basel) 2019;11:816.
[CROSSREF] [PUBMED] [PMC]
30. Selvaggi SM. The presence of multinucleated giant cells: noninvasive follicular thyroid neoplasm with papillary-like nuclear features vs the follicular variant of papillary thyroid carcinoma. Diagn Cytopathol 2019;47:1007-10.
[CROSSREF] [PUBMED]
31. Brooks E, Simmons-Arnold L, Naud S, Evans MF, Elhosseiny A. Multinucleated giant cells’ incidence, immune markers, and significance: a study of 172 cases of papillary thyroid carcinoma. Head Neck Pathol 2009;3:95-9.
[CROSSREF] [PUBMED] [PMC]
32. Dvorak K, Aggeler B, Palting J, McKelvie P, Ruszkiewicz A, Waring P. Immunohistochemistry with the anti-BRAF V600E (VE1) antibody: impact of pre-analytical conditions and concordance with DNA sequencing in colorectal and papillary thyroid carcinoma. Pathology 2014;46:509-17.
[CROSSREF] [PUBMED] [PMC]
33. Singarayer R, Mete O, Perrier L, Thabane L, Asa SL, Van Uum S, et al. A systematic review and meta-analysis of the diagnostic performance of BRAFV600E immunohistochemistry in thyroid histopathology. Endocr Pathol 2019;30:201-18.
[CROSSREF] [PUBMED]
34. Choden S, Keelawat S, Jung CK, Bychkov A. VE1 immunohistochemistry improves the limit of genotyping for detecting BRAFV600E mutation in papillary thyroid cancer. Cancers (Basel) 2020;12:596.
[CROSSREF] [PUBMED] [PMC]
35. Bychkov A, Hirokawa M, Jung CK, Liu Z, Zhu Y, Hong SW, et al. Low rate of noninvasive follicular thyroid neoplasm with papillary-like nuclear features in Asian practice. Thyroid 2017;27:983-4.
[CROSSREF] [PUBMED]